Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DR26FBSDH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,330
Award facts
- Contract value 100% obligated
- $11,330.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,330.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, employs firm fixed-price pricing with no set-aside designation, allowing the contractor to compete directly against larger competitors. DMS Pharmaceutical Group's substantial federal contracting activity and established performance across multiple therapeutic categories positioned it to secure this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supplying pharmaceutical products to military healthcare facilities worldwide. The parent IDC, designated contract SPE2DR with a $500 million ceiling and completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare operations globally. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group continues to fulfill specialized pharmaceutical requirements essential to military medical operations.
Quick answers
Who was awarded contract SPE2DR26FBSDH?
SPE2DR26FBSDH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FBSDH worth?
The government has obligated $11,330 on SPE2DR26FBSDH.
Is contract SPE2DR26FBSDH an order under another contract?
Yes. SPE2DR26FBSDH is a delivery order under SPE2DR25D9158, an indefinite delivery contract.
Was contract SPE2DR26FBSDH competed?
The extent of competition for SPE2DR26FBSDH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award